Clinical Trials Browser

Phase 1 × Adenocarcinoma × Docetaxel × Clear all

NCT07316686 2026-01-05

Lutécio

Phase 1 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT04361708 2025-10-01

I-FLOAT

Phase 1 Recruiting

Adenocarcinoma

NCT01685489 2015-10-27

A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancer

Phase 1 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Neoplasms, Prostatic Neoplasms